The effects of switching antidepressants on endoxifen exposure.

Trial Profile

The effects of switching antidepressants on endoxifen exposure.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Nov 2011

At a glance

  • Drugs Escitalopram (Primary) ; Paroxetine (Primary) ; Tamoxifen; Venlafaxine
  • Indications Breast cancer
  • Focus Adverse reactions; Pharmacogenomic; Pharmacokinetics
  • Acronyms Switch
  • Most Recent Events

    • 11 Nov 2011 New source identified and integrated (Netherlands Trial Register)
    • 11 Nov 2011 Planned end date changed to 7 Nov 2014 as reported by Netherlands Trial Register.
    • 09 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top